The cytoprotective response mediated by HSF1 counteracts the cytotoxic effect of proteasome inhibitors (51, 52, 53), and thus, HSF1 inhibition might be effective to overcome proteasome inhibitor resistance in cancer cells. Here, HSF1 is linked to cancer.